What is the challenge?

Governments want to maximize the health of their citizens while managing scarce healthcare resources. A key challenge is to determine the health interventions that provide the most benefit to patients and the most value to taxpayers. HTA is the cornerstone of decision-making in many countries around the world.

Regulators, HTA bodies, payers, providers and patients need to understand the real impact of a new health technology/intervention on “Patients’” function, feeling and preferences prior to licensing, listing and reimbursing. All stakeholders assess the quality and reliability of patient-centred evidence in addition to its value for money in deciding whether to reimburse new health technologies.

HTA can be a complex and time-consuming process. HTA practitioners must have the knowledge, skills and experience to deeply understand the health technology, its clinical and economical impacts on patients and health systems. Involving a trustworthy partner or vendor like QHTA will help you meet these challenges.